ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial

First ENHERTU trial in Western patients with gastric cancer Efficacy and safety results consistent with pivotal DESTINY-Gastric01 trial; will support ongoing discussions with global health authorities TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINES...

Full "IntellAsia: Resources" article